Phase 2 Type 1 Diabetes Trial, Recruiting (NCT07083882)

Phase 2 Type 1 Diabetes Trial, Recruiting NCT07083882 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07083882 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have recently been diagnosed with type 1 diabetes within the last 100 days.
You are between 18 and 45 years old.
Your Body Mass Index (BMI) is between 18 and 30 (a measure of weight relative to height).
Your body is still producing some of its own insulin, shown by a detectable level of a substance called C-peptide in your blood or urine at the start of the study.

Who may not be able to join:

You have a serious illness affecting a major organ or body system.
You have a weakened immune system, or are expected to have one, for example due to recent chemotherapy or HIV with a low immune cell count (confirm with trial site).
You have a history of a serious digestive condition, such as celiac disease, long-lasting diarrhoea, severe constipation, or Inflammatory Bowel Disease (IBD).
You have used recreational drugs such as MDMA, amphetamines, cocaine, heroin, or GHB in the past three months, or plan to during the study.
You drink more than 21 units of alcohol per week on average over the past three months.
You are currently pregnant or breastfeeding.
You are unable to give your own informed consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 020 566 9111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07083882

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase: Phase 2

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 020 566 9111

More information: https://clinicaltrials.gov/study/NCT07083882

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have recently been diagnosed with type 1 diabetes within the last 100 days.
You are between 18 and 45 years old.
Your Body Mass Index (BMI) is between 18 and 30 (a measure of weight relative to height).
Your body is still producing some of its own insulin, shown by a detectable level of a substance called C-peptide in your blood or urine at the start of the study.

Who may not be able to join:

You have a serious illness affecting a major organ or body system.
You have a weakened immune system, or are expected to have one, for example due to recent chemotherapy or HIV with a low immune cell count (confirm with trial site).
You have a history of a serious digestive condition, such as celiac disease, long-lasting diarrhoea, severe constipation, or Inflammatory Bowel Disease (IBD).
You have used recreational drugs such as MDMA, amphetamines, cocaine, heroin, or GHB in the past three months, or plan to during the study.
You drink more than 21 units of alcohol per week on average over the past three months.
You are currently pregnant or breastfeeding.
You are unable to give your own informed consent to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

1 September 2029

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Preservation of residual beta cell insulin secretion capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov